Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-26

Clinical Trial Update: Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy of celecoxib versus placebo to prevent pain during paced walking in knee osteoarthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Knee Osteoarthritis | Phase 4 | Status: COMPLETED